Cell Reports (Nov 2024)

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity

  • Dong Sun Oh,
  • Eunha Kim,
  • Rachelly Normand,
  • Guangqing Lu,
  • Lydia L. Shook,
  • Amanda Lyall,
  • Olyvia Jasset,
  • Stepan Demidkin,
  • Emily Gilbert,
  • Joon Kim,
  • Babatunde Akinwunmi,
  • Jessica Tantivit,
  • Alice Tirard,
  • Benjamin Y. Arnold,
  • Kamil Slowikowski,
  • Marcia B. Goldberg,
  • Michael R. Filbin,
  • Nir Hacohen,
  • Long H. Nguyen,
  • Andrew T. Chan,
  • Xu G. Yu,
  • Jonathan Z. Li,
  • Lael Yonker,
  • Alessio Fasano,
  • Roy H. Perlis,
  • Ofer Pasternak,
  • Kathryn J. Gray,
  • Gloria B. Choi,
  • David A. Drew,
  • Pritha Sen,
  • Alexandra-Chloé Villani,
  • Andrea G. Edlow,
  • Jun R. Huh

Journal volume & issue
Vol. 43, no. 11
p. 114933

Abstract

Read online

Summary: Pregnancy is a risk factor for increased severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory infections, but the mechanisms underlying this risk are poorly understood. To gain insight into the role of pregnancy in modulating immune responses at baseline and upon SARS-CoV-2 infection, we collected peripheral blood mononuclear cells and plasma from 226 women, including 152 pregnant individuals and 74 non-pregnant women. We find that SARS-CoV-2 infection is associated with altered T cell responses in pregnant women, including a clonal expansion of CD4-expressing CD8+ T cells, diminished interferon responses, and profound suppression of monocyte function. We also identify shifts in cytokine and chemokine levels in the sera of pregnant individuals, including a robust increase of interleukin-27, known to drive T cell exhaustion. Our findings reveal nuanced pregnancy-associated immune responses, which may contribute to the increased susceptibility of pregnant individuals to viral respiratory infection.

Keywords